Moy Fincher Chipps

What Moy Fincher Chipps does

Moy Fincher Chipps, operating commercially as Rodeo Derm (rodeoderm.com), is a multi-location dermatology and facial plastic surgery practice founded in 1994 by Dr. Ronald Moy in the South Bay area of Los Angeles. The practice operates three clinical sites: a Beverly Hills headquarters at 421 N. Rodeo Drive, a Torrance location on Pacific Coast Highway, and an Encino location in the San Fernando Valley. Clinical care is delivered by four board-certified, fellowship-trained dermatologists (Drs. Edgar Fincher, Lisa Chipps, Lauren Moy, and William Kwan), supported by two physician assistants, one nurse practitioner, and registered nursing staff. Service lines are organized into Medical Dermatology (skin cancer screening and Mohs micrographic surgery, acne, eczema, psoriasis, rosacea, and general skin conditions), Cosmetic Dermatology (a broad laser and energy-based device suite, injectables, body contouring, hair restoration, hormone therapy), and Facial Cosmetic Surgery (facelift, neck lift, brow lift, blepharoplasty, liposuction, canthopexy, nano fat grafting).

The technology base is a multi-platform dermatology device inventory rather than a software platform. Key devices include fractionated CO2 and Erbium lasers, PiQo4 picosecond pigment and tattoo laser, Clear + Brilliant, Lutronic Ultra Lase MD non-ablative fractional, Xtrac targeted UVB, EmbraceRF, Pelleve, Pollogen, and microneedling RF for skin tightening. Injectables span neuromodulators (BOTOX, Dysport, Jeuveau) and dermal fillers / biostimulators (Restylane, Juvederm, Radiesse, Sculptra, Kybella), complemented by PRP / PRF regenerative treatments. Mohs micrographic surgery with same-day reconstruction is the signature medical-surgical offering, with claimed cure rates near 99% and tissue-sparing outcomes.

The business model is a hybrid of insurance-reimbursed medical dermatology and self-pay cosmetic and surgical services. The practice accepts most major PPO carriers and Medicare for covered medical services and collects self-pay fees for cosmetic procedures, with Good Faith Estimates available per federal requirements and financing options via the Golden State Dermatology network. Go-to-market is direct-to-consumer, driven by a content-marketing-heavy website, an SEO-optimized blog archive, Instagram (@mfcdermatology), Facebook, YouTube, patient testimonials, and earned media in SouthBay Magazine, Glamour, Beverly Hills Courier, and FORE Magazine. Online booking is delivered through Luma Health and bill payment through POS Corp under the Golden State Dermatology umbrella. In 2024, the practice became an affiliate of Golden State Dermatology, a comprehensive medical, surgical, and cosmetic dermatology network across the Western U.S., enabling standardized back-office, shared dermatopathology, and a path to broader SoCal expansion while preserving physician-led operations at the practice level. No private equity or venture capital ownership is indicated in available sources.

Name

Moy Fincher Chipps

Legal name

Moy-Fincher-Chipps Facial Plastics & Dermatology

Website

https://rodeoderm.com

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

11–50 employees

Short description

Moy Fincher Chipps (Rodeo Derm) is a Los Angeles-area dermatology and facial plastic surgery practice offering medical dermatology, Mohs surgery, cosmetic procedures, and facial plastic surgery across three locations in Beverly Hills, Torrance, and Encino. The practice is affiliated with the Golden State Dermatology network.

Ownership category

akta.pro rank

Product category

Dermatology and Facial Plastic Surgery Services

akta.pro primary industry

General & Medical Dermatology (HLAKACAA)

akta.pro secondary industry

Mohs Surgery & Skin Cancer (Dermatologic Oncology) (HLAKACAD)

Keywords

• Medical dermatology services
• Cosmetic dermatology procedures
• Mohs micrographic surgery
• Facial plastic surgery
• Laser skin treatments

Headquarters

HQ city

Torrance

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Medical Dermatology Services: Billable medical dermatology services including skin cancer screening, Mohs surgery, treatment of acne, eczema, psoriasis, rosacea, and other medical skin conditions. Most major PPO insurance carriers and Medicare are accepted.
2. Cosmetic Dermatology Procedures: Cosmetic procedures including laser treatments, injectables (BOTOX, fillers), body contouring, and other aesthetic services. These are self-pay/cosmetic fees not covered by insurance.
3. Facial Plastic Surgery: Surgical procedures including facelift, neck lift, eyelid surgery, brow lift, and liposuction. Self-pay cosmetic surgery services.
4. Golden State Dermatology Network Affiliation: Part of a larger multi-site dermatology organization with expanded services and dermatopathology, providing access to expanded resources and system-wide patient support.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

Core offering

Moy Fincher Chipps is a multi-location dermatology and facial plastic surgery practice delivering medical dermatology (skin cancer screening, Mohs micrographic surgery, treatment of chronic skin conditions), cosmetic dermatology (laser treatments, neuromodulators, dermal fillers, body contouring, hair restoration, hormone therapy), and facial cosmetic surgery (facelift, neck lift, eyelid surgery, brow lift, liposuction). Services are delivered through three clinics in Beverly Hills, Torrance, and Encino, supported by an extensive in-house laser and energy-based device suite and a network of board-certified, fellowship-trained physicians.

Product overview

Moy Fincher Chipps is a multi-location dermatology and facial plastic surgery practice operating as three distinct service lines: Medical Dermatology (including Mohs micrographic surgery for skin cancer), Cosmetic Dermatology (laser treatments, injectables, body contouring, hair restoration, hormone therapy), and Facial Cosmetic Surgery (facelift, neck lift, eyelid surgery, brow lift, liposuction). The practice utilizes an extensive laser suite featuring Fractionated CO2, Fractionated Erbium, PiQo4, Clear + Brilliant, Lutronic Ultra Lase MD, and Xtrac. Injectable offerings include neuromodulators (BOTOX, Dysport, Jeuveau) and dermal fillers (Restylane, Juvederm, Radiesse, Sculptra, Kybella), plus PRP/PRF regenerative treatments. Radiofrequency technologies include microneedling RF, EmbraceRF, Pelleve, and Pollogen. Surgical services are centralized for facial plastic surgery with integrated dermatologic follow-up.

Differentiator

Problem solved

Functional benefit

Products and services

• Medical Dermatology
• Mohs Micrographic Surgery
• Skin Cancer Screening and Prevention
• Cosmetic Laser and Light Treatments
• Cosmetic Injectables (Neuromodulators and Dermal Fillers)
• PRP and PRF Therapy
• Radiofrequency and Microneedling Treatments
• Hair Restoration
• Body Contouring and Liposuction
• Facial Cosmetic Surgery
• Sclerotherapy and Vein Treatment
• Scar Improvement
• Hormone Replacement Therapy

Quantifiable outcome

• Mohs surgery cure rate close to 99% with smallest possible scars
• +1 more outcomes

Named customers6 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

Feature5 records

Partnerships

Two partnerships are on record, tiered core and supporting.

• Golden State DermatologycoreStrategic or Co-development PartnerMoy-Fincher-Chipps became an affiliate of Golden State Dermatology, a comprehensive medical, surgical and cosmetic dermatology network with locations throughout the Western US. This partnership expands GSD's footprint from the Bay Area and California's Central Valley into Southern California. The partnership allows enhanced and expanded ability to provide top-notch care to medical and cosmetic patients.
• Golden State Dermatopathology LabsupportingTechnology or IntegrationAffiliated with dermatopathology lab offering advanced diagnostic services for skin, hair, and nail conditions. Board-certified dermatopathologists review every case personally, enabling direct consultation with referring physicians for precise diagnoses.

Scale indicators6 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• QualDerm Partners: PE-backed dermatology platform with a multi-site network spanning medical, surgical, and cosmetic dermatology across multiple states. Comparable as a broader incumbent in the same consolidation wave that MFC has joined via Golden State Dermatology.
• Forefront Dermatology: Large multi-state dermatology group offering medical, surgical, and cosmetic dermatology with substantial Mohs capacity. Operates as a scaled platform competing for the same physician talent and patient referrals.
• U.S. Dermatology Partners: One of the largest PE-backed dermatology platforms in the U.S., operating hundreds of locations across medical, surgical, and cosmetic dermatology. A scaled incumbent rather than a direct specialty competitor, but competes for the same referral pipelines and physician talent.
• APDerm: PE-backed multi-location dermatology platform in the Northeast and Mid-Atlantic combining medical, surgical, and cosmetic dermatology with significant Mohs surgery volume, structurally similar to the GSD model MFC has joined.

Direct peers

• Advanced Dermatology PC: Multi-location medical and cosmetic dermatology practice with multiple fellowship-trained Mohs surgeons and an extensive laser offering, similar in physician mix and service line breadth to Moy Fincher Chipps.
• SkinCare Physicians: Multi-specialty dermatology group in the Northeast combining medical dermatology, Mohs surgery, cosmetic dermatology, and plastic surgery under one roof with fellowship-trained physicians, closely mirroring MFC's integrated service model.
• Schweiger Dermatology Group: One of the largest PE-backed multi-location dermatology practices in the U.S., offering medical, surgical, and cosmetic dermatology across dozens of offices. Highly comparable to MFC in service mix (Mohs, injectables, lasers) and in pursuing scale through geographic expansion, though materially larger and platform-owned.
• Goldman Dermatology: Multi-physician New York dermatology practice offering medical dermatology, Mohs surgery, lasers, injectables, and cosmetic procedures with a similar physician-led, multi-modality service profile.

Regional players

• West Dermatology: California-based multi-location dermatology network offering medical, surgical, and cosmetic dermatology across Southern and Central California. Overlaps with MFC's service lines within the same California geography and is now a sister/affiliate network via Golden State Dermatology.
• Cosmetic Laser Dermatology: San Diego-based multi-physician dermatology practice with deep laser and injectables expertise and research-grade technology suite. Comparable to MFC in its emphasis on advanced lasers, injectables, and physician-led cosmetic dermatology in the Southern California market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@MoyFincherChipps
• Facebookfacebook.com/rodeoderm
• Instagraminstagram.com/mfcdermatology
• Xx.com/MFCDermatology
• LinkedInlinkedin.com/company/about

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Moy Fincher Chipps